Healthcare Professionals
Please log in for special information and services
New here?
sign up for personal account

Product Details

Remodulin® is used to treat idiopathic or hereditary pulmonary arterial hypertension (PAH) in patients with medium to severe symptoms.

Remodulin® 1 mg/ml, 2,5 mg/ml, 5 mg/ml,10 mg/ml injections.

Ferrer Internacional, S.A is the MA-Holder and AOP Orphan has the distribution right.

Patient Information Leaflet Remodulin® in German  

Drug Facts

Active ingredient

Treprostinil